Cargando…

Functional genomics and the future of iPSCs in disease modeling

Induced pluripotent stem cells (iPSCs) are valuable in disease modeling because of their potential to expand and differentiate into virtually any cell type and recapitulate key aspects of human biology. Functional genomics are genome-wide studies that aim to discover genotype-phenotype relationships...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brooks, Imogen R., Garrone, Cristina M., Kerins, Caoimhe, Kiar, Cher Shen, Syntaka, Sofia, Xu, Jessie Z., Spagnoli, Francesca M., Watt, Fiona M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133703/ https://www.ncbi.nlm.nih.gov/pubmed/35487213 http://dx.doi.org/10.1016/j.stemcr.2022.03.019

Ejemplares similares

Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

The Challenge of Bringing iPSCs to the Patient
por: Ortuño-Costela, María del Carmen, et al.
Publicado: (2019)

Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages
por: Lipus, Alexandra, et al.
Publicado: (2020)

Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015)

Applications of iPSCs in Cancer Research
por: Kim, Jean J
Publicado: (2015)

Reducing genomic instability in iPSCs
por: Ruiz, Sergio, et al.
Publicado: (2015)

iPSCs in Modeling and Therapy of Osteoarthritis
por: Csobonyeiova, Maria, et al.
Publicado: (2021)

iPSCs: From Bench to Clinical Bed
por: Li, Yujing, et al.
Publicado: (2016)

Differentiation of human iPSCs into functional podocytes
por: Rauch, Caroline, et al.
Publicado: (2018)

Common genetic variation drives molecular heterogeneity in human iPSCs
por: Kilpinen, Helena, et al.
Publicado: (2017)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
por: Carter, Ava C., et al.
Publicado: (2014)

Disease, iPSCs and a Quest for the Perfect Model
Publicado: (2016)

Clinical Therapy Using iPSCs: Hopes and Challenges
por: Lu, Xiao, et al.
Publicado: (2013)

The Potential of iPSCs for the Treatment of Premature Aging Disorders
por: Compagnucci, Claudia, et al.
Publicado: (2017)

The tale of autologous iPSCs: A monkey perspective
por: Li, Fei
Publicado: (2014)

Tumorigenicity risk of iPSCs in vivo: nip it in the bud
por: Zhong, Chaoliang, et al.
Publicado: (2022)

Modelling urea cycle disorders using iPSCs
por: Duff, Claire, et al.
Publicado: (2022)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022)

AT7867 promotes pancreatic progenitor differentiation of human iPSCs
por: Cuesta-Gomez, Nerea, et al.
Publicado: (2023)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)

CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
por: Sen, Tirthankar, et al.
Publicado: (2022)

Modelling DMD-associated cardiomyopathy in patient-derived iPSCs
Publicado: (2015)

The State of Play with iPSCs and Spinal Cord Injury Models
por: Hodgetts, Stuart I., et al.
Publicado: (2015)

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs
por: Menon, Siddharth, et al.
Publicado: (2016)

Epigenetic Modifiers Facilitate Induction and Pluripotency of Porcine iPSCs
por: Mao, Jian, et al.
Publicado: (2016)

Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs
por: Kim, Eunhye, et al.
Publicado: (2016)

Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018)

The rebirth of iPSCs: Towards a healthier epigenetic landscape
por: Li, Fei
Publicado: (2014)

Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
por: Yoshihara, Masahito, et al.
Publicado: (2016)

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells
por: Hor, Pooja, et al.
Publicado: (2020)

Pannexin 1 Influences Lineage Specification of Human iPSCs
por: Noort, Rebecca J., et al.
Publicado: (2021)

iPSCs and Exosomes: Partners in Crime Fighting Cardiovascular Diseases
por: Germena, Giulia, et al.
Publicado: (2021)

Improved and Flexible HDR Editing by Targeting Introns in iPSCs
por: Fu, Juan, et al.
Publicado: (2022)

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
por: Cichocki, Frank, et al.
Publicado: (2023)

The Defects of Epigenetic Reprogramming in Dox-Dependent Porcine-iPSCs
por: Jiang, Aiwen, et al.
Publicado: (2022)

Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons
por: Castillo Bautista, Cristina Marisol, et al.
Publicado: (2023)

Understanding the pathophysiology of NOMID arthropathy for drug discovery by iPSCs technology
por: Nakagawa, K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e7a1adverfqo7hbr45927pkacp